You are invited to the next Swiss Healthcare Club Fireside Chat Series, featuring Boris L. Zaïtra, Head of Group Business Development / M&A at Hoffmann-La Roche, and moderated by Eric de la Fortelle, MBA ‘99D.
Current Trends and Future Direction of Pharma Deal-Making
9 Feb 2023
Partnerships and acquisitions play an increasingly central role in pharmaceutical innovation.
This one-hour in-person discussion is a unique opportunity for the INSEAD community to engage with Boris and explore what these trends could mean for the future of health.
Boris L. Zaïtra
Head of Group Business Development - Mergers & Acquisitions, Business Development Finance and Real Estate Transactions
Boris is Head of Group Business Development / M&A at Hoffmann-La Roche and is based in Basel, Switzerland: in this role, he leads Roche’s strategic mergers and acquisitions as well as Real Estate divestments across the Roche Group businesses and supports Pharma in-licensing transactions on the finance side. Boris joined Roche in April 2012 from the Airbus Group where he worked for seven years as Head of the Mergers & Acquisitions department. Prior to joining Airbus in late 2005, he was a Partner with the mid-market private equity firm Duke Street Capital and was involved in deals in the UK and France. Previously, he was an M&A Associate with JP Morgan in London, focusing primarily on the Oil & Gas industry.
Boris graduated from Ecole Polytechnique in France in 1995 and the Harvard Advanced Management Programme in 2009 (AMP 177). He is married with two young children.
Eric de la Fortelle, MBA ‘99D, Swiss Healthcare Club leadership team member